Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GEO accession GSE237331 is currently private and is scheduled to be released on May 31, 2026.

ABSTRACT: GEO accession GSE237331 is currently private and is scheduled to be released on May 31, 2026.

PROVIDER: PRJNA994586 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Transcriptional profiling of liver biopsies of precancerous viral hepatitis patients: Validation cohort

Project description:We used RNA-seq to map the transcriptomes of archived formalin-fixed paraffin-embedded (FFPE) liver biopsies from precancerous chronic viral hepatitis patients with known clinical outcome. This Series contains the validation cohort used to validate the predictive transcriptomic signature.

2025-12-02 | GSE237331 | GEO

Transcriptional profiling of liver biopsies of precancerous viral hepatitis patients: Training cohort

Project description:We used RNA-seq to map the transcriptomes of archived formalin-fixed paraffin-embedded (FFPE) liver biopsies from precancerous chronic viral hepatitis patients with known clinical outcome. This Series contains the training cohort used to generate the predictive transcriptomic signature.

2025-12-02 | GSE237330 | GEO

Transcriptional profiling of liver biopsies of precancerous viral hepatitis patients: Training cohort

Project description:Transcriptional profiling of liver biopsies of precancerous viral hepatitis patients: Training cohort

| PRJNA994585 | ENA

Transcriptional profiling of liver biopsies of precancerous viral hepatitis patients

Project description:Transcriptional profiling of liver biopsies of precancerous viral hepatitis patients

| PRJNA994581 | ENA

Tuberculosis biomarker validation cohort

Project description:Tuberculosis biomarker validation cohort

| PRJNA616117 | ENA

Validation of differentially methylated DNA regions in colorectal precancerous lesions.

Project description:Validation of differentially methylated DNA regions in colorectal precancerous lesions.

| PRJEB59896 | ENA

Discovery and validation of urinary molecular signature of early sepsis (validation cohort)

Project description:Discovery and validation of urinary molecular signature of early sepsis (validation cohort)

| PRJNA439295 | ENA

Transcriptome profiles of liver biopsy tissues from sever alcoholic hepatitis patients (validation cohort, Brussels)

Project description:Corticosteroids are the current standard of care to improve short_term mortality in severe alcoholic hepatitis (AH), although nearly 40% of the patients do not respond and accurate pre_treatment predictors are lacking. We developed 123_gene prognostic score based on molecular and clinical variables before initiation of corticosteroids. Furthermore, The gene signature was implemented in an FDA_approved platform (NanoString), and verified for technical validity and prognostic capability. Here we demonstrated that a Nanostring_based gene expressoin risk classificatoin is useful to predict mortality in patients with severe alcoholic hepatitis who were treated by corticosteroid

2018-02-18 | GSE94399 | GEO

Validation of differentially methylated DNA regions in colorectal precancerous lesions.

Project description:In this study, we validated 992 previously identified differentially methylated regions (DMRs) in colorectal precancerous lesions compared to adjacent normal mucosa in a new series of 59 prospectively collected lesions and matched normal tissue using targeted bisulfite sequencing. Strong differences in methylation level were observed across the full set of validated DMRs. Based on the mean methylation levels of a panel of 30 selected DMRs tumors could be accurately classified. We thus provide a large list of validated DNA markers to be exploited in the development of noninvasive, colorectal tumor screening assays.

2023-03-30 | E-MTAB-12612 | biostudies-arrayexpress

mRNA expression in ulcerated primary cutaneous melanoma (validation cohort)

Project description:mRNA expression in ulcerated primary cutaneous melanoma (validation cohort)

| PRJNA868798 | ENA